V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20143901 | 20087735 | 1.75 | 75 | Palliative (P) | 2019-02-09 | 2019-02-09 | SCOPE 2 TRIAL | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101252005 |
| 20143988 | 20087736 | 1.7 | 40 | Palliative (P) | 2019-08-01 | 2019-08-08 | CISPLATIN + RT | 02 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 101187221 |
| 20144063 | 20087737 | 1.73 | 48.9 | null | 2018-04-22 | 2018-05-14 | CISPLATIN + FLUOROURACIL + Trastuzumab | 01 | N | NIVOLUMAB | 100273877 |
| 20144258 | 20087738 | 1.6 | 54.4 | null | 2018-09-05 | 2018-09-12 | Hydroxycarbamide | 02 | N | GEMCITABINE + PACLITAXEL | 100486743 |
| 20144687 | 20087739 | 1.76 | 63.5 | Palliative (P) | 2017-03-04 | 2017-04-01 | Capecitabine + Docetaxel | 02 | N | LENALIDOMIDE | 100262936 |
| 20144724 | 20087740 | 1.7 | 62 | Palliative (P) | 2019-10-30 | 2019-11-13 | Cytarabine Low Dose | 02 | N | ABIRATERONE | 100377009 |
| 20144775 | 20087742 | 1.61 | 47 | Adjuvant (A) | 2018-10-10 | 2018-10-12 | EVEROLIMUS | 02 | N | DOCETAXEL | 100830644 |
| 20144788 | 20087743 | null | 77.5 | Palliative (P) | 2019-07-14 | 2019-07-14 | EVEROLIMUS | 02 | N | RITUXIMAB | 100418670 |
| 20144809 | 20087744 | 1.77 | 60.08 | null | 2019-04-04 | 2019-04-11 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100361698 |
| 20144867 | 20087745 | null | 62.6 | Neo-adjuvant (N) | 2016-08-12 | 2016-08-12 | Abiraterone | 01 | null | ARISTOTLE TRIAL | 100413733 |
| 20145020 | 20087747 | 1.82 | 88.7 | Curative (C) | 2018-01-06 | 2018-01-11 | ACELARATE Trial | 02 | N | PAZOPANIB | 101754439 |
| 20145152 | 20087748 | 1.55 | 93 | null | 2017-09-01 | 2017-09-07 | Bortezomib +/- Dexamethasone | Y | N | SCOPE2 TRIAL | 100628854 |
| 20145257 | 20087749 | 1.6 | 56.4 | 03 | null | 2019-03-30 | Hydroxycarbamide | N | N | CARBOPLATIN + FLUOROURACIL | 100879817 |
| 20145263 | 20087750 | 1.57 | 61 | 03 | 2019-08-07 | 2019-08-25 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | GEMCARBO | 100179937 |
| 20145424 | 20087751 | 1.56 | 55 | Palliative (P) | 2017-10-30 | 2017-11-25 | Carbo F | 02 | N | EOF | 101806526 |
| 20145949 | 20087753 | 1.54 | 91.65 | Palliative (P) | 2018-06-05 | 2018-06-07 | null | 02 | N | PHITT | 101661215 |
| 20145973 | 20087754 | 1.8 | 82.5 | Palliative (P) | 2020-01-13 | 2020-01-13 | GO2 TRIAL | 02 | N | FOXTROT TRIAL | 101486697 |
| 20146044 | 20087755 | 1.77 | 66.6 | 03 | 2018-10-06 | 2018-10-12 | Ralitrexed | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100280594 |
| 20146204 | 20087757 | 1.62 | 87.25 | 03 | 2018-03-06 | 2018-03-06 | CAPECITABINE + CETUXIMAB + IRINOTECAN | Y | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101472009 |
| 20146362 | 20087759 | 1.75 | 73.9 | Palliative (P) | 2020-03-02 | 2020-03-09 | SCOPE 2 TRIAL | 02 | N | ACELARATE TRIAL | 100714816 |
| 20146423 | 20087760 | 1.66 | 90 | 03 | 2018-03-03 | 2018-03-09 | PLATO Trials | 02 | N | PLATO TRIAL | 101120411 |
| 20146565 | 20087761 | 1.73 | 78 | Adjuvant (A) | 2018-03-08 | 2018-04-04 | Gemcitabine + Paclitaxel | 2 | N | NIVOLUMAB | 100751944 |
| 20146817 | 20087762 | 1.73 | 77.8 | 03 | 2019-12-19 | 2020-01-14 | Bortezomib (weekly) | null | N | CHLORAMBUCIL + RITUXIMAB | 101014132 |
| 20147061 | 20087763 | 1.63 | 92.5 | null | 2020-03-27 | 2020-03-27 | Sunitinib | 02 | N | ESPAC TRIAL | 101498959 |
| 20147170 | 20087764 | 1.78 | 62 | Adjuvant (A) | 2016-07-31 | 2016-08-27 | Sunitinib | 02 | N | GEMCARBO | 101789225 |
| 20147197 | 20087765 | 1.58 | 58.3 | Palliative (P) | null | 2018-03-25 | BALLAD Trial | null | N | RALTITREXED | 100843358 |
| 20147238 | 20087766 | 1.83 | null | Palliative (P) | 2019-08-11 | 2019-08-21 | BORTEZOMIB + THALIDOMIDE | 02 | null | CISPLATIN + VINORELBINE | 100388128 |
| 20147266 | 20087767 | 1.71 | 40 | Palliative (P) | 2019-06-29 | 2019-07-07 | Paclitaxel 7 day | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101108584 |
| 20147289 | 20087768 | 1.55 | 70.8 | Palliative (P) | 2018-01-11 | 2018-01-23 | FOXTROT TRIAL | null | N | PACLITAXEL | 100292964 |
| 20147403 | 20087769 | 1.85 | 60 | 03 | 2016-04-19 | 2016-04-23 | FEC | 02 | N | ACTICCA-1 TRIAL | 100772465 |
| 20147512 | 20087770 | 1.69 | 52.7 | 03 | 2019-06-12 | 2019-06-12 | CAPECITABINE + OXALIPLATIN + RT | 02 | null | GEMCITABINE + PACLITAXEL | 100244003 |
| 20147523 | 20087771 | 1.88 | 73 | null | 2017-07-22 | 2017-07-27 | EOF | 02 | N | CARBOPLATIN + PEMETREXED | 101375847 |
| 20147747 | 20087773 | 1.67 | 87.6 | 03 | 2020-02-08 | 2020-02-19 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 101456224 |
| 20147923 | 20087774 | 1.75 | null | Palliative (P) | 2022-02-24 | 2022-02-24 | PEMBROLIZUMAB | 01 | N | MITOMYCIN | 101479851 |
| 20148036 | 20087775 | 1.83 | 93 | Palliative (P) | 2019-06-02 | 2019-06-02 | Olaparib | 02 | N | TEMOZOLOMIDE | 100507784 |
| 20148059 | 20087776 | 1.83 | 86 | Palliative (P) | 2019-12-20 | 2019-12-20 | null | 02 | null | AZACITIDINE | 100347012 |
| 20148157 | 20087777 | 1.84 | 123.1 | null | 2014-08-13 | 2014-08-19 | Hydroxycarbamide | 2 | Y | IPILIMUMAB + NIVOLUMAB | 100483990 |
| 20148182 | 20087778 | 1.73 | 71.1 | 03 | 2018-11-11 | 2018-11-13 | Sunitinib | 02 | N | ARISTOTLE TRIAL | 101627462 |
| 20148251 | 20087779 | null | 20.7 | null | 2019-05-11 | 2019-05-26 | Cisplatin + Radiotherapy | 02 | N | NOT MATCHED | 100803425 |
| 20148325 | 20087780 | 1.71 | 79 | Adjuvant (A) | 2020-07-03 | 2020-07-06 | null | N | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101071880 |
| 20148558 | 20087781 | 1.89 | 98.35 | Palliative (P) | null | 2019-06-16 | ECarboX | 02 | Y | BENDAMUSTINE + RITUXIMAB | 101213518 |
| 20148637 | 20087782 | 1.73 | 97.6 | 03 | 2021-05-08 | 2021-05-08 | Capecitabine + Streptozocin | 02 | N | DOCETAXEL | 101141868 |
| 20148640 | 20087783 | 1.67 | null | 03 | 2020-11-11 | 2020-12-05 | ECarboX | N | N | RITUXIMAB | 100605586 |
| 20148788 | 20087784 | null | null | 03 | 2017-02-21 | 2017-03-05 | Cisplatin + Fluorouracil + RT 5day | N | Y | CAPECITABINE + LOMUSTINE | 100907601 |
| 20149019 | 20087785 | 1.8 | 103 | 03 | 2019-07-13 | 2019-07-18 | ECarboX | 02 | Y | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101631269 |
| 20149178 | 20087786 | 1.77 | 61.7 | Palliative (P) | 2017-07-20 | 2017-08-02 | IRINOTECAN + MdG + OXALIPLATIN + PANITUMUMAB | 02 | N | HYDROXYCARBAMIDE | 101299694 |
| 20149286 | 20087787 | 1.65 | 97 | Palliative (P) | null | 2019-03-07 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | N | NIVOLUMAB | 101393517 |
| 20149311 | 20087788 | 1.85 | 69.8 | Palliative (P) | 2018-05-11 | 2018-05-12 | CAP + RT | 02 | N | DOXORUBICIN | 101059622 |
| 20149386 | 20087789 | 1.5 | 85.8 | 03 | 2019-11-04 | 2019-11-23 | EEF or EOF | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100119472 |
| 20149394 | 20087790 | 1.64 | 53.6 | null | 2016-11-04 | 2016-11-08 | ARISTOTLE TRIAL | 01 | N | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 100234040 |